Explain this page
Arphra AIPlain-English read on ResMed Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.17% | -10.82% | -9.06% | -27.25% | -24.94% | -22.60% | -23.60% | -14.75% | -9.60% | +215.09% | +27649.00% |
Aftermarket
LiveLast trade
$188.00
89 sh
Bid
$185.66
20 sh
Ask
$189.34
20 sh
Spread
$3.680
Sector & industry today
LiveSectors
- Technology+3.30%
- Basic Materials+0.98%
- Energy+0.83%
- Consumer Cyclical+0.49%
- Industrials+0.25%
- Communication Services+0.13%
- Healthcare-0.65%
- Financial Services-0.80%
- Consumer Defensive-0.84%
- Utilities-1.15%
- Real Estate-1.32%
Top industries (issuer's industry highlighted)
- Medical - Devices-0.34%
- Computer Hardware+8.35%
- Software - Infrastructure+7.61%
- Consulting Services+5.28%
- Coal+5.20%
- Manufacturing - Metal Fabrication+4.24%
- Staffing & Employment Services+4.08%
- Gambling, Resorts & Casinos+3.71%
- Broadcasting+3.70%
- Integrated Freight & Logistics+3.68%
- REIT - Healthcare Facilities-3.49%
- Software - Application+3.44%
Fair value
Football field →Weighted blend
$372.38
+99.73% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
5bull11bear
±5% threshold
Analyst PT consensus: $281.29 (+50.87%)
Total assets
$8.17B
Total debt
$851.81M
Cash & equiv
$1.21B
Operating CF
$1.75B
Free cash flow
$1.66B
Buybacks
-$300.03M
Analyst view
DB · price_targets + analyst_gradesConsensus target
$281.29
+50.87% upside
Low
$225.00
Median
$275.00
High
$345.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 Mar 2026 | $1.43B | $398.73M | $2.71 |
| Q2 Dec 2025 | $1.42B | $392.59M | $2.68 |
| Q1 Sep 2025 | $1.34B | $348.54M | $2.37 |
| Q4 Jun 2025 | $1.35B | $379.71M | $2.58 |
| Q3 Mar 2025 | $1.29B | $365.04M | $2.48 |
| Q2 Dec 2024 | $1.28B | $344.62M | $2.34 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Farrell Michael J. director, officer: Chairman and CEO | Sell | 4,991 | $1.13M | Apr 07, 2026 |
Sandercock Brett officer: Chief Financial Officer | Sell | 1,000 | $224.31K | Apr 01, 2026 |
FARRELL PETER C director | Sell | 2,000 | $450K | Apr 01, 2026 |
Farrell Michael J. director, officer: Chairman and CEO | Sell | 4,991 | $1.25M | Mar 09, 2026 |
FARRELL PETER C director | Sell | 2,000 | $520.44K | Mar 04, 2026 |
Sandercock Brett officer: Chief Financial Officer | Sell | 1,000 | $254.3K | Mar 02, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $5.15B | $1.69B | $1.4B | $9.51 | +27.22% |
| FY 2024 | $4.69B | $1.32B | $1.02B | $6.92 | +21.79% |
| FY 2023 | $4.22B | $1.13B | $897.56M | $6.09 | +21.25% |
| FY 2022 | $3.58B | $1B | $779.44M | $5.30 | +21.78% |
| FY 2021 | $3.2B | $903.68M | $474.51M | $3.24 | +14.84% |